SCHEMBL23217979

SCHEMBL23217979

C=CCN(C(=O)OC(C)(C)C)c1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 1/20 0.38
LMNA P02545 2/20 0.37
POLB P06746 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
GSTO1 P78417 1/20 0.35
RIPK1 Q13546 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
ACLY P53396 1/20 0.34
MAPT P10636 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
HIF1A Q16665 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23218018 0.88 LMNA (0.40) ALDH1A1L3MBTL1KMT2ALMNAPOLB
SCHEMBL28038900 0.85 CYP3A4 (0.43) ALDH1A1L3MBTL1KMT2ATSHRLMNA
SCHEMBL29009658 0.84 L3MBTL1 (0.38) ALDH1A1L3MBTL1KMT2ATSHRGSTO1
SCHEMBL26345840 0.81 CTSS (0.44) ALDH1A1LMNAPOLBCTSSCTSK
SCHEMBL6822857 0.81 RIPK1 (0.39) ALDH1A1L3MBTL1KMT2ALMNAPOLB
SCHEMBL4832911 0.81 LMNA (0.41) ALDH1A1L3MBTL1LMNAPOLBCTSS
SCHEMBL28859253 0.81 L3MBTL1 (0.36) ALDH1A1L3MBTL1KMT2ATSHRPOLB
SCHEMBL26345821 0.77 POLB (0.41) ALDH1A1L3MBTL1KMT2ALMNAPOLB
SCHEMBL3160825 0.77 TSHR (0.37) ALDH1A1L3MBTL1KMT2ATSHRLMNA
SCHEMBL6207086 0.77 L3MBTL1 (0.33) ALDH1A1L3MBTL1KMT2ATSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed